High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer. (Q36431610)
Jump to navigation
Jump to search
scientific article published in January 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer. |
scientific article published in January 1997 |
Statements
High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer (English)
A G Zeimet
M Uhl-Steidl
E Müller-Holzner
G Daxenbichler
C Marth
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference